- Home
- TLPH vs CXH Comparison
TLPH vs CXH Comparison
Compare TLPH & CXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLPH | CXH |
|---|---|---|
| Founded | 2005 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 65.0M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLPH | CXH |
|---|---|---|
| Price | $1.00 | $8.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 475.9K | 25.9K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | ★ $28,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $33.35 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $6.41 |
| 52 Week High | $1.57 | $7.74 |
Technical Indicators
Market Signals| Indicator | TLPH | CXH |
|---|---|---|
| Relative Strength Index (RSI) | 38.49 | 62.71 |
| Support Level | $0.97 | $7.97 |
| Resistance Level | $1.07 | $8.10 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 9.37 | 79.52 |
Price Performance
Historical ComparisonAbout TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About CXH MFS Investment Grade Municipal Trust
Mfs Investment Grade Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowing for investment purposes, in tax-exempt bonds and tax-exempt notes.